MAnual Lymphatic DrAinage to iMprove the outcomE of Patients After Septic Shock
Key facts
- Who runs it
- University Hospital Ostrava
- Where
- Czechia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 24 people enrolled
- Started
- 1 Jun 2023
- Ended
- 28 Nov 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Manual Lymphatic Drainage
- Usual Care
- Record updated
- 12 December 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- diagnosis of septic shock at admission to ICU
- sepsis or suspicion of sepsis
- noradrenaline support required in order to maintain mean arterial pressure ≥ 65 mmHg
- serum lactate ≥ 2 mmol/L
Who cannot take part
- patients with septic shock transferred from another department/hospital, if the length of stay at the previous workplace exceeded 72 hours
- patients with a history of heart failure with NYHA (New York Heart Association) classification ≥ III
- patients with a history of thromboembolic events
- patients with uncontrolled infection
- patients <18 years of age
- pregnant women with septic shock, in whom the pregnancy has been preserved
- patients with septic shock and an inauspicious prognosis, or in the phase of withdrawal of treatment
- patients with septic shock who lack informed consent
- patients with septic shock, in whom the SOFA score decreased by more than 50% during the day following the withdrawal of noradrenaline (i.e. a subgroup of patients with a rapid improvement of the clinical course after the resolution of septic shock)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Antimicrobial and supportive therapeutic interventions in patients with septic shock are usually effective - procalcitonin and interleukin-6 levels fall rapidly in most cases, and noradrenaline support can be discontinued within a few days. Unfortunately, only in a small portion of patients, do the organ functions improve at the same time, and in most of them, multi-organ failure persists. Therefore, it is likely that, in addition to infection and the response to infection, other mechanisms are also involved in the persistence of organ failure in patients after septic shock.
The 2 groups in the trial
- Manual Lymphatic DrainageTreatment being tested
In addition to usual care, daily manual lymphatic drainage will be performed for five consecutive days. After this period.
- Usual CareExisting treatment, for comparison
Usual care for patients with septic shock will be provided.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- MAnual Lymphatic DrAinage to iMprove the outcomE of Patients After Septic Shock: A Safety and Feasibility Pilot Randomized Controlled Trial
- Record updated
- 12 December 2025